Gts Securities LLC Exact Sciences Corp Call Options Transaction History

Gts Securities LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	BUY	$42.43 - $70.83 $492,188 - $821,628	11,600 Added 26.61%	55,200 $3.76 Million
Q2 2024 Aug 14, 2024	SELL	$41.33 - $74.26 $7.32 Million - $13.1 Million	-177,000 Reduced 80.24%	43,600 $1.84 Million
Q1 2024 May 15, 2024	BUY	$56.27 - $73.77 $8.65 Million - $11.3 Million	153,800 Added 230.24%	220,600 $15.2 Million
Q4 2023 Feb 14, 2024	BUY	$59.06 - $75.72 $35,436 - $45,432	600 Added 0.91%	66,800 $4.94 Million
Q3 2023 Nov 15, 2023	BUY	$65.94 - $99.04 $4.37 Million - $6.56 Million	66,200 New	66,200 $4.52 Million

672

163M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.9B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.